Maddy Kennedy brings 20+ years of expertise in life science & technology sectors to NuroKor’s leadership team.
Own part of healthcare’s future with equity in NuroKor from as little as £12*. Capital at risk.
NuroKor appoints new distribution partner in the US
NuroKor welcomes their new Content Writer, Andrew Bradshaw, to the team.
Pain and wound management expert Dr. Irem Tezer Ates talks about endometriosis and how NuroKor can help.
To enhance its communications, NuroKor is delighted to welcome Matt Williams to the team.
New patient research demonstrates reduction or elimination of pain for 91% with NuroKor technologies.
After a record year of phenomenal growth, NuroKor has appointed Matt James as Chief Operating Officer
Award-winning Creative Lead Jonathan Corns is the latest addition at NuroKor, as its team grows.
New clinical project to examine effect of NuroKor bioelectric technology on osteoarthritis patients
After a period of sustained growth, NuroKor has appointed Aelin Raines as Executive Operations Manager.
Tanja Novakovic joins as Creative Director - focussing on design and development of the NuroKor brand.
Shaina Kumar joins as Communications Lead to drive the communications strategy across all marketing touchpoint
Physiotherapist & NuroKor Norway Distributor Hilde Hjertholm on the pandemic's impact on physio practices
New partnership launched to reduce absenteeism and help disabled workers return to workforce
Director of Clinical Affairs, Wim Laloo will lead the strategy and development of NuroKor's clinical studies
Mum-of-three, Chantelle McCabe able to reduce her painkiller intake by 85% after using NuroKor technology
The NuroKor team continue to grow, dual-qualified lawyer Jo Rogers becomes NuroKor's Head of Legal
Learn about the role bioelectrical stimulation has in wound care and how NuroKor's Woundtech division can help
We explore how bioelectronics can assist period pain, endometriosis and other female specific pain ailments
NuroKor spearheads US growth through 5-year partnership with Medi-Launch Partners and opening of R&D centre
NuroKor announces 3rd key appointment for 2021, Jonathan Penny Chief Commercial Officer - Medical & Clinical
NuroKor announces a key clinical addition to its team with the appointment of Consultant Orthopaedic Surgeon.
Clare Smith shares how NuroKor technology has helped her lower her dependence on painkillers
Electrical Stimulation can support patients and clinicians pre- and post-surgical interventions, learn more.
Pharmacists see demand for pain clinics increase by up to 47% since first lockdown. NuroKor technology assists
The strain of the pandemic sees UK healthcare professionals choosing to fund the technology of the future
NuroKor welcomes senior global sales and marketing professional William Ripley as CCO - Consumer Markets
Consultant orthopedic surgeon and avid runner Mr Tim Owen MB BCH FRCS (ENG) FRCS (Orth) on plantar fasciitis
Dr Ardeshir Bayat collates his laboratory and clinical research on Electrical Stimulation for wound healing
Dr. Ashish Shetty (MBBS, FRCA, FFPMRCA) joins NuroKor team as Chief Medical Officer - Pain & Neuromodulation
Achilles tendon injuries impact 11,000 people in the UK, microcurrent stimulation can assist treatment process
NuroKor introduces new General Manager for Australian Market, Gemma Fitzsimons
NuroKor announces partnership with CPD Certification Service, to develop first bielectronic medicine course.
Genomics analysts Muhdo and bioelectronics experts NuroKor to launch personalised health profile KorDNA
Ardeshir Bayat is a Medical Research Council funded Professor at the University of
In this episode of The BioElectronics Podcast, we speak to rugby legend Brynmor Williams about trigger finger.
We are excited to introduce the latest NuroKor team member Dr Irem Tezer who joins as Medical Science Director
We are joined on the podcast by Brenda Lloyd, an NHS nurse with decades of experience treating patients.
We talk with world-renowned orthopaedic surgeon Jeremy Latham and discuss the future of the healthcare sector.
In this episode we talk to physiotherapist and CEO of NuroKor Norway Hilde Hjertholm about her clinical career
Our CEO is interviewed on the Talking Health Tech podcast to explain bioelectronics and NuroKor's advancements
Anaesthetists have used bioelectronics for decades, we discuss how it is utilised and the need for an update.
NuroKor CEO Rick Rowan is interviewed on Wellbeing Radio, to discuss bioelectronics and wearable technology.
The second installment of The BioElectronics Podcast delves into microcurrent and its benefit. Listen here.
Episode 1 of The BioElectronics Podcast answers the age old question, 'what is bioelectronics?'. Listen here.
We are launching our podcast, the first of its kind on the topic of bioelectronics in the health tech space
We explore TPNS Application and how patients and clinicians can best utilise in adjusting to remote work
We review what clinicians need to know about our technology and answer our most frequently asked questions
We share how NuroKor’s medically regulated products deliver personalised pain relief to patients.
NuroKor shares how it's technology can become a cost-effective, drug-free alternative to conventional medicine
NuroKor shares how it's independant research is placing the company at the forefront of bioelectric medicine.
The NuroKor series addresses evidence led, bioelectronic tech and its place amongst healthcare and clinicians.
White paper exploring the clinical and cost benefits of treating diabetes with electroceuticals
James and Rick talk chronic back-pain suffer,Rick's motivations and combatting the opioid epidemic..
Lateral epicondylitis, also known as tennis elbow, is a tendinopathy of the arm ...
Mitochondria consume about 85% of oxygen used by cells during ATP production & extremely important function...
As people are seeking out healthier options to treat their pains, bioelectronics is proving an answer.
Whether by intuition or by accidental discovery, the use of bioelectrical stimulation to treat....
Rick Rowan talks with Joy Radio about NuroKor & the passion behind the brand...
The results of a new clinical trial...